Skip to content
Screener

Olema Pharmaceuticals, Inc. OLMA Prepaid & Other Current

Prepaid & Other Current at other companies

Eli Lilly logo
Eli LillyLLY
$15.37B-14.7%
LON
LeonaBio, Inc.LONA
$1.52M-52.2%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$8.3M+7.7%
Opko Health logo
Opko HealthOPK
$55.74M-5.3%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$10.12M-20.3%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$18.35M+19.4%

Other financials

Income statement

See full
Operating income-$58.0M-66.3%
Net income-$53.1M-74.7%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$52.5M+3.8%
Total debt$956.0K-16.7%
Total equity$480.5M+25.3%
Total assets$530.6M+29.5%

Cash flow

See full
Operating cash flow-$46.0M-4.6%
CapEx-
Free cash flow-$34.5M-27.8%

Valuation

See full
Market cap$1.05B+237%
Enterprise value$1B+282%

Returns & leverage

See full
Return on equity-42.9%+1.3pp
Debt / equity0.0×
Current ratio10.9×-4.3×

Where this comes from

Reported directly by Olema Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 7:10 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-218156
Line itemMarch 31, 2026December 31, 2025
Current assets:
Cash and cash equivalents$52,547$48,301
Marketable securities452,800457,136
Prepaid expenses and other current assets7,88210,015
Total current assets513,229515,452
Operating lease right-of-use assets9211,146
Other assets and long-term deposits16,49516,832
Total assets$530,645$533,430

Item 1. Financial Statements.

FAQ

What is Olema Pharmaceuticals, Inc.'s prepaid & other current?
Olema Pharmaceuticals, Inc. (OLMA) reported prepaid & other current of $7.88M in Q1 2026.
How has Olema Pharmaceuticals, Inc.'s prepaid & other current changed year-over-year?
Olema Pharmaceuticals, Inc.'s prepaid & other current increased by 99.2% year-over-year, from $3.96M to $7.88M.
What is the long-term trend for Olema Pharmaceuticals, Inc.'s prepaid & other current?
Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s prepaid & other current has grown at a 20.9% compound annual growth rate (CAGR), from $11.77M to $25.15M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Olema Pharmaceuticals, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude